Beyond the semi-synthetic artemisinin: metabolic engineering of plant-derived 
anti-cancer drugs

Carqueijeiro, I.; Langley, Chloe; Grzech, Dagny; Koudounas, K.; Papon, N.; O’Connor, Sarah E.; Courdavault, V.

doi:10.1016/j.copbio.2019.11.017

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Beyond the semi-synthetic artemisinin: metabolic engineering of plant-derived anti-cancer drugs

MPS-Authors

/persons/resource/persons244889

Langley, Chloe
Department of Natural Product Biosynthesis, Prof. Dr. Sarah O'Connor, MPI for Chemical Ecology, Max Planck Society;
IMPRS on Ecological Interactions, MPI for Chemical Ecology, Max Planck Society;

/persons/resource/persons244870

Grzech, Dagny
Department of Natural Product Biosynthesis, Prof. Dr. Sarah O'Connor, MPI for Chemical Ecology, Max Planck Society;
IMPRS on Ecological Interactions, MPI for Chemical Ecology, Max Planck Society;

/persons/resource/persons228440

O’Connor, Sarah E.
Department of Natural Product Biosynthesis, Prof. Dr. Sarah O'Connor, MPI for Chemical Ecology, Max Planck Society;

External Resource

https://doi.org/10.1016/j.copbio.2019.11.017
(Publisher version)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

SOC092.pdf
(Publisher version), 744KB

Supplementary Material (public)

There is no public supplementary material available

Citation

Carqueijeiro, I., Langley, C., Grzech, D., Koudounas, K., Papon, N., O’Connor, S. E., et al. (2020). Beyond the semi-synthetic artemisinin: metabolic engineering of plant-derived anti-cancer drugs. Current Opinion in Biotechnology, 65, 17-24. doi:10.1016/j.copbio.2019.11.017.

Cite as: https://hdl.handle.net/21.11116/0000-0005-9989-4

Abstract

There is no abstract available